Newark, New Castle, USA, Feb. 01, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Facial Injectables Market by Product (Botulinum Toxin [Botox], Collagen, and Hyaluronic Acid), by Application (Aesthetics & Therapeutics) and End User (Hospitals & Dermatologic Clinics) – Global Outlook and Forecast 2020-2030" published by Growth Plus Reports, the facial injectables market is expected to grow at a CAGR of 10.28% from 2021 to reach US$ 15.41 billion by 2030. Facial injectables emerge as a promising option for treatment and improving the life of COVID-19 patients.
The global facial injectables market has been analysed from four different perspectives – product, application, end user, and region.
Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/facial-injectables-market/8075
Excerpts from ‘By Product Segmentation’
Based on the products the global facial injectable market is segmented into:
- Botulinum Toxin (Botox)
- Collagen
- Hyaluronic Acid (HA)
- Calcium Hydroxylaptite (Caha)
- Fat Injections
- Polymer Filters
- Others
The polymer filters segment is further divided into polylactic acid, and Polymethylmethacrylate Microspheres (PMMA). The botox segment held the largest revenue share of the global facial injectables market in 2021. Botox is well renowned for giving a gorgeous, young, and refreshed face. Because it is non-invasive and frequently produces effects quickly. According to a report published in August 2022, botox is the most popular non-invasive procedure. In the U.S., botox is administered to more than 7.4 million patients. A post-pandemic Botox craze might be driven by people who seek to lessen the signs of ageing brought on by stress. During the lockdown, fewer individuals travelled and spent less money at pubs and restaurants, which gave them more money to spend on medical operations. Additionally, the relatively simple process of receiving botox injections from a trained expert may boost the popularity of the jab. Eventually, a few injections can rapidly minimize the impression of wrinkles and fine lines, which can provide those who are estranged from friends and family a small boost in self-confidence. The growing usage of botulinum toxin injectable in several aesthetic procedures, such as the therapy of glabellar lines, artificial browlifts, and forehead lines, is predicted to fuel market expansion in the upcoming years. Only a few type-A products and one type-B product of botulinum toxin are now available on the market (Myobloc). Major producers are expanding their investment in R&D activities to examine the therapeutic use of the toxin, despite the likelihood that the therapeutic use area for botulinum toxin will expand in the near future.
Excerpts from ‘By Application Segmentation’
Based on the applications the global facial injectables market is classified as:
- Aesthetics
- Therapeutics
The aesthetics segment is further segmented as facial line correction, lip augmentation, face lift, acne scar treatment, lipoatrophy treatment, and others. The aesthetic segment dominated the global facial injectables market in 2021. There is an increase in the use of facial injectables for aesthetic procedures like lip augmentation, lip augmentation, lip border restoration, lip lines, glabellar lines, perioral lines, crow's feet lines, furrows (deep wrinkles), periorbital wrinkles, superficial lines, marionette lines, lipoatrophy of the face, and nasopharyngeal. Due to an increase in middle-class affluence in emerging countries like India and a growing interest in physical beauty, the demand for face injectables for cosmetic purposes is expected to increase in the coming years. In developing nations, the middle-class population's rising disposable income and increased interest in physical appearance are anticipated to raise demand for facial injectables for aesthetic purposes in the upcoming years. A fastest CAGR is estimated for the therapeutic segment. This is explained by an increase in the use of facial injectables for the treatment of blepharospasm, Meige's syndrome, oromandibular dystonia (OMD), strabismus or crossed eyes, hemifacial spasms (HFS), and focal hyperhidrosis.
Inquiry Before Buying: https://www.growthplusreports.com/inquiry/before-buying/facial-injectables-market/8075
Excerpts from ‘By Region Segmentation’
Based on the regional segmentation the global facial injectables market is divided as:
- North America
- Europe
- Asia Pacific
- Rest of the world
The largest market share is expected to be held by North America in 2021. Increased consumer knowledge and understanding of aesthetic cosmetic surgeries, technological developments in cosmetic procedures, the presence of major market players, the rising geriatric population, and consumer demand for non-invasive aesthetic procedures are some of the factors propelling market growth in the North American region. The feed - in tariff policies, the regulatory regime, and the accessibility of cutting-edge medical infrastructure and technology are all factors driving the market's expansion in this area. Also, population growth is causing a rise in the demand for scar, blemish, and anti-aging treatments. The demand for cosmetic improvement operations such as face injections is growing. American society places a greater focus on looking young, hence there is a dire demand for anti-aging treatments. Over the past 10 years, the value of one's aesthetic appearance has expanded, which has boosted the range of non-invasive therapies available on a global scale. As a result, an increasing number of people are electing to undergo these procedures. The market is growing as a result of the prevalence of minimally invasive procedures and their increased popularity.
Excerpts from ‘Competitive landscape’
The regional expansion, product introductions, and approval of those products, as well as their improvement in already-existing technology, are all influenced by certain rival competitors. These players develop product strategies, work with other businesses to meet aesthetic requirements, and control their market shares for facial injectables. This accelerates the market for facial injectables' growth and gives other businesses additional alternatives. The key companies operating the global facial injectable market are:
- Ipsen
- Merz Pharma
- Suneva Medical, Inc.
- Medytox Inc.
- Sinclair Pharma
- Bloomage Biotechnology Corporation Limited
- Anika Therapeutics Inc.
- Prollenium Medical Technologies
- Galderma
- Allergan, Inc.
- Nestle Skin Health
- Zimmer Biomet
- Abbvie Inc
- SciVision Biotech Inc
- Croma-Pharma GmbH
- Revance Therapeutics Inc
- Bioplus Co. Ltd
- Bioaxis Pharmaceuticals
Table of Content
- INTRODUCTION
-
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecasted Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
-
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
-
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
-
- Drivers
- Restraints/Challenges
- Opportunities
TOC Continued..
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Request for Customization – https://www.growthplusreports.com/inquiry/customization/facial-injectables-market/8075
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
